2019/03/11 by Russel M. Vincent, Bradley W. Wright, Paul R. Jaschke · 1 citation
Biochemistry, Genetics and Molecular Biology · #RNA and protein synthesis mechanisms #RNA modifications and cancer #Bacterial Genetics and Biotechnology
paper · doi:10.1021/acssynbio.9b00021
openalex publication_date 2019/03/11 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/30
Using engineered initiator tRNA for precise control of protein translation within cells has great promise within future orthogonal translation systems to decouple housekeeping protein metabolism from that of engineered genetic systems. Previously, E. coli strain C321.ΔA. exp lacking all UAG stop codons was created, freeing this “amber” stop codon for other purposes. An engineered “amber initiator” tRNA CUA fMet that activates translation at UAG codons is available, but little is known about this tRNA’s orthogonality. Here, we combine for the first time the amber initiator tRNA CUA fMet in C321.ΔA. exp and measure its cellular effects. We found that the tRNA CUA fMet expression resulted in a nearly 200-fold increase in fluorescent reporter expression with a unimodal population distribution and no apparent cellular fitness defects. Proteomic analysis revealed upregulated ribosome-associated, tRNA degradation, and amino acid biosynthetic proteins, with no evidence for off-target translation initiation. In contrast to previous work, we show that UAG-initiated proteins carry N-terminal methionine, but have no evidence for glutamine. Together, our results identify beneficial features of using the amber initiator tRNA CUA fMet to control gene expression while also revealing fundamental challenges to using engineered initiator tRNAs as the basis for orthogonal translation initiation systems.